The diagnostic and molecular characteristics of malignant mesothelioma and ovarian/peritoneal serous carcinoma

被引:33
|
作者
Davidson, B. [1 ,2 ]
机构
[1] Oslo Univ Hosp, Dept Pathol, Norwegian Radium Hosp, Div Pathol, N-0310 Oslo, Norway
[2] Univ Oslo, Fac Med, Oslo, Norway
关键词
cytology; malignant mesothelioma; serous carcinoma; effusion; diagnosis; cancer biology; COMPARATIVE GENOMIC HYBRIDIZATION; EPITHELIAL OVARIAN-CANCER; FOLATE RECEPTOR-ALPHA; PLEURAL MESOTHELIOMA; PERITONEAL MESOTHELIOMA; DIFFERENTIAL-DIAGNOSIS; MONOCLONAL-ANTIBODY; GROWTH-FACTOR; LAMININ RECEPTOR; POOR SURVIVAL;
D O I
10.1111/j.1365-2303.2010.00829.x
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The diagnostic and molecular characteristics of malignant mesothelioma and ovarian/peritoneal serous carcinoma Malignant mesothelioma and ovarian/peritoneal serous carcinoma are two of the most common tumours affecting the serosal cavities. Unlike other malignant tumours diagnosed at this anatomical site, such as lung and breast carcinoma, malignant mesothelioma and serous carcinoma share a common histogenesis, may be difficult to differentiate morphologically, and co-express many of the diagnostic markers used by cytopathologists in effusion diagnosis. Selected markers have nevertheless shown sufficient sensitivity and specificity to differentiate serous carcinoma from malignant mesothelioma effectively. Recently, our group applied high throughput technology to the identification of new markers that may aid in differentiating these two cancer types and validated several of these markers in follow-up studies. This review will present current data regarding the diagnostic and biological aspects of malignant mesothelioma and ovarian/peritoneal serous carcinoma.
引用
收藏
页码:5 / 21
页数:17
相关论文
共 50 条
  • [21] A case of localized peritoneal malignant mesothelioma with ovarian metastasis and literature review
    Wang, J. I. N. G. W. E. N.
    Hu, R. O. N. G.
    He, Q. I. A. N.
    MEDICINA DEL LAVORO, 2022, 113 (04):
  • [22] Malignant peritoneal mesothelioma without asbestos exposure: An ovarian cancer imitator
    Grzankowski, Kassondra S.
    Brightwell, Rachel M.
    Kasznica, John M.
    Odusi, Kunle O.
    GYNECOLOGIC ONCOLOGY REPORTS, 2015, 11 : 10 - 12
  • [23] Serum HMGB1 as a Diagnostic Marker for Malignant Peritoneal Mesothelioma
    Tabata, Chiharu
    Kanemura, Shingo
    Tabata, Rie
    Masachika, Eriko
    Shibata, Eisuke
    Otsuki, Tai-Ichiro
    Nishizaki, Tomoyuki
    Nakano, Takashi
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 2013, 47 (08) : 684 - 688
  • [24] Diagnostic Accuracy of Calretinin for Malignant Mesothelioma in Serous Effusions: a Meta-analysis
    Li, Diandian
    Wang, Bo
    Long, Hongyu
    Wen, Fuqiang
    SCIENTIFIC REPORTS, 2015, 5
  • [25] Potentiation of cisplatin and carboplatin cytotoxicity by amphotericin B in different human ovarian carcinoma and malignant peritoneal mesothelioma cells
    Poulain, L
    Sichel, F
    Crouet, H
    Bureau, F
    Gauduchon, P
    Gignoux, M
    LeTalaer, JY
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1997, 40 (05) : 385 - 390
  • [26] Potentiation of cisplatin and carboplatin cytotoxicity by amphotericin B in different human ovarian carcinoma and malignant peritoneal mesothelioma cells
    Laurent Poulain
    François Sichel
    Hubert Crouet
    François Bureau
    Pascal Gauduchon
    Marc Gignoux
    Jean-Yves Le Talaër
    Cancer Chemotherapy and Pharmacology, 1997, 40 : 385 - 390
  • [27] Serum Thioredoxin-1 as a Diagnostic Marker for Malignant Peritoneal Mesothelioma
    Tabata, Chiharu
    Terada, Takayuki
    Tabata, Rie
    Yamada, Shusai
    Eguchi, Ryoji
    Fujimori, Yoshihiro
    Nakano, Takashi
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 2013, 47 (01) : E7 - E11
  • [28] SOX6 Expression Is Sensitive for Peritoneal Epithelioid Malignant Mesothelioma, But Not Specific in the Differential Diagnosis With Tubo-ovarian Serous Neoplasia
    Chapel, David B.
    Hirsch, Michelle S.
    AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2022, 46 (02) : 213 - 219
  • [29] Diffuse malignant peritoneal mesothelioma
    Shih, Chih-An
    Ho, Szu-Pei
    Tsay, Feng-Woei
    Lai, Kwok-Hung
    Hsu, Ping-I
    KAOHSIUNG JOURNAL OF MEDICAL SCIENCES, 2013, 29 (11) : 642 - 645
  • [30] Malignant peritoneal mesothelioma.
    Loggie B.W.
    Current Treatment Options in Oncology, 2001, 2 (5) : 395 - 399